Copyright
©The Author(s) 2017.
World J Diabetes. Feb 15, 2017; 8(2): 40-44
Published online Feb 15, 2017. doi: 10.4239/wjd.v8.i2.40
Published online Feb 15, 2017. doi: 10.4239/wjd.v8.i2.40
Ref. | Country | Patients enrolled | Site of management | Therapy used | Outcome | Length of stay |
Dunbar et al[12] Retrospective study (January 1994 - March 1995) | United States | 61 | 15: ICU 46: Regular floor | Not mentioned | Mortality due to sepsis in only 1 patient with initial pH < 7.00 | ICU: 2 d Regular floor: Not mentioned |
Umpierrez et al[14] Prospective randomized open trial | United States | 45 | 15: ICU 30: ED | ICU: Intravenous insulin drip ED: 15 subcutaneous insulin aspart Q1H ED: 15 subcutaneous insulin aspart Q2H | Hypoglycemic event presented in each group in only 1 patient per group. No complications, no recurrence of ketoacidosis and no mortality | ICU: 4.5 ± 3 d ED with SC Q1H: 3.4 ± 3 d ED with SC Q2H 3.9 ± 3 d |
Karoli et al[15] Prospective randomized open trial (January 2009 - June 2010) | India | 50 | 25: ICU 25: ED | ICU: 25 intravenous regular insulin ED: 25 subcutaneous insulin lispro | Hypoglycemic event presented, 2 patients in the ICU group and 1 patient in the ED group. No complications, no recurrence of ketoacidosis and no mortality | ICU: 6.6 ± 1.5 d ED: 6.0 ± 1.2 d |
Ersöz et al[16] Prospective randomized open trial | Turkey | 20 | 20: ICU | ICU: 10 intravenous regular insulin ICU: 10 subcutaneous insulin lispro | No need to switch to IV regular insulin, no hypoglycemic events, no complications, no recurrence of ketoacidosis and no mortality | Not mentioned |
Umpierrez et al[18] Prospective randomized open trial | United States | 20 | 10: ICU 10: MW | ICU: 20 intravenous regular insulin IMU: 10 subcutaneous insulin lispro Regular floor: 10 subcutaneous insulin lispro | Hypoglycemic event presented in each group in only 1 patient per group, no complications, np recurrence of ketoacidosis and no mortality | IMU and Regular floor: 4 ± 2 d ICU: 4 ± 1 d |
Sotiropoulos et al[25] Prospective study (June 2007 - May 31 2008) | Greece | 21 | 21: ED | ED: 21 intravenous regular insulin | Myocardial infarction in only 1 patient - Mortality 4.7% | Not mentioned |
Della Manna et al[26] Controlled clinical trial (June 2001 - June 2003) | Brazil | 60 | 3: ICU 57: ED | ICU: 3 intravenous regular insulin ED: 27 intravenous regular insulin ED: 30 subcutaneous insulin lispro | Hypoglycemic event on 10 patients, 6 patients due to regular insulin and 4 due to lispro; no complications, no recurrence of ketoacidosis and no mortality | Not mentioned |
Myocardial infarction |
Congestive heart failure |
Acute renal failure |
Acute respiratory failure |
Altered mental status |
Coma |
Shock |
Hypothermia |
Sepsis |
Pancreatitis |
Gastrointestinal bleeding |
Uncontrolled hypertension |
End stage renal disease |
Hyperkalemia |
- Citation: Mendez Y, Surani S, Varon J. Diabetic ketoacidosis: Treatment in the intensive care unit or general medical/surgical ward? World J Diabetes 2017; 8(2): 40-44
- URL: https://www.wjgnet.com/1948-9358/full/v8/i2/40.htm
- DOI: https://dx.doi.org/10.4239/wjd.v8.i2.40